This article is more than 5 years old. Information may no longer be current.

Quantel gets 510(k) clearance for laser system to treat retinal diseases

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The U.S. Food and Drug Administration has granted 510(k) market clearance for the SupraScan 577 laser system, Quantel Medical announced in a news release.

The laser combines 577-nm yellow wavelength, pattern scanning and Iridex MicroPulse tissue-sparing laser emission modes in a single system, according to the release.

The 577 nm yellow wavelength is used for treatment of retinal diseases because of its high absorption in oxyhemoglobin and low absorption in xanthophyll pigments, along with its ability to efficiently transmit through opaque ocular media, the release said.

The SupraScan 577 is the first yellow laser available in the U.S. that offers pattern scanning in both conventional and tissue-sparing MicroPulse modes, according to the release.